Skip to content

HEMARTY Hemorrhoid Artery Minimalisation A Randomized Trial of a ligation Therapy (Doppler guided HAL versus non-doppler guided HAL procedure)

HEMARTY Hemorrhoid Artery Minimalisation A Randomized Trial of a ligation Therapy (Doppler guided HAL versus non-doppler guided HAL procedure) - HEMARTY

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON30975
Enrollment
100
Registered
2008-01-29
Start date
2008-02-25
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

piles

Interventions

First group is treated with the HAL procedure with doppler. The second group is treated with the HAL procedure without doppler.

Sponsors

Sint Antonius Ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Age above 18 years Complains for more than 3 months of haemorrhoid related complains Haemorrhoid Grade 2 resistant to rubber band ligation Haemorrhoid Grade 3 ASA 1 and 2

Exclusion criteria

Exclusion criteria: Previous gastro-intestinal malignancy Previous surgery in the rectum including treatment for haemorrhoids within the last 10 years. Simultaneously presence of other anal disorders, such as anal fissure, fistula, abscess, colon/anus carcinoma Unable to understand instructions (eg. Language barrier)

Design outcomes

Primary

MeasureTime frame
Cost effectiveness analyses of the artery ligations procedures.

Secondary

MeasureTime frame
To establish the reduction of anal blood flow (decrease of vessel diameter) in both groups as measured with intra anal Duplex before and after the procedure. Next to the changes in rectal compliance in both groups as measured with anal manometry before and after the procedure. Other secondary parameter/endpoints involve the next items • The duration of the procedure • Post operative complications (VAS score) • Post operative pain

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)